Wall Street kicked off the final trading days of March with a split decision on Monday, as the Dow inched higher while the S&P 500 and Nasdaq slipped under the weight of faltering chip stocks and surging oil prices above 100 dollars…
Stocks limped into the close after dropping sharply throughout Thursday's session as oil prices spiked and Big Tech finally remembered stocks can, in fact, go down, with Wall Street nervously watching the Strait of Hormuz and its own valuation multiples at the…
Kodiak Sciences (KOD, $38.33, +68.51%) is back in Wall Street’s good graces today, and for once in biotech, the data and the stock are rowing in the same direction .
GLOW2 Shines On Diabetic Retinopathy
Kodiak reported positive topline results from its…
Olaplex (NASDAQ: OLPX), the science-driven haircare innovator, has captured Wall Street's attention with its bond-building technology and strategic pivot, culminating in a blockbuster $1.4 billion acquisition by Henkel, a leading global manufacturer of well-known consumer and industrial brands. Amid resilient Q4 sales…
U.S. stocks extended their relief rally on Wednesday, as Wall Street decided that a 15-point peace plan beats a $115 oil quote almost every time.
Indexes Rebound as War Premium Bleeds Out
Major indexes climbed after reports that Washington had sent Tehran…
Yes indeed, Eupraxia Pharmaceutical's (NASDAQ: EPRX) EP-104 is quietly auditioning for a starring role in eosinophilic esophagitis—and for once, the gastroenterologist, the allergist, and the payer might actually clap at the same time.
A Chronic Disease Finally Meets a Long-Term Plan
Eosinophilic…
GeoVax’s (GOVX) latest update on its GEO-MVA program reads less like a small-cap press release and more like a biotech coming-of-age story, with Phase 3 now on the horizon and global health agencies finally circling the dance floor. For investors, the mpox/smallpox…
Merck (MRK) is preparing to spend nearly $6 billion in cash to acquire Terns Pharmaceuticals (TERN), a move that reads like a carefully scripted sequel to its Keytruda blockbuster rather than an impulsive spin-off. The price represents a premium to Terns’ roughly…
Spider-Man just did what Wall Street dreams of: turned a teaser into a trillion‑eyeball asset class, becoming the first movie trailer in history to cross 1 billion views in just four days across platforms. The result is not just a win for…
Wall Street gave back part of Monday’s euphoric bounce on Tuesday as oil roared back above $92 and Middle East headlines reminded investors that risk never really takes a day off.
Indices: Rally Hangover, Not a Meltdown
US stocks slipped, but the…